Jan 11 (Reuters) - Vitrolife AB:
* VITROLIFE ACQUIRES LICENSING RIGHTS TO TECHNOLOGY FOR EMBRYO TRANSFER
* SAYS ‍INTENDS TO COMMERCIALISE TECHNOLOGY BY MARKETING A UNIQUE EMBRYO TRANSFER CATHETER​
* SAYS ‍INITIAL PURCHASE PRICE AMOUNTED TO USD 5 MILLION​ * SAYS ‍ACQUISITION IS EXPECTED TO IMPACT EBITDA PER SHARE MARGINALLY NEGATIVELY DURING 2018-2020 AND POSITIVELY AS FROM 2021​ Source text for Eikon: Further company coverage:
Our Standards: The Thomson Reuters Trust Principles.